Endogenous Progenitor Cell Repair in Multiple Sclerosis

Investigators: Samuel Weiss (project leader), University of Calgary; Voon Wee Yong, University of Calgary; Jack Antel, McGill University; Luanne Metz, University of Calgary.

Project summary: Building on previously funded SCN research, this project includes basic research and a clinical trial to identify and test the role of prolactin, a pituitary hormone, in the repair of damaged myelin in patients with Multiple Sclerosis (MS).

Benefits: The overall goal is to develop a novel therapeutic approach to treat MS patients.

Term: 2008 - 2012